Open AccessAdefovir and Tenofovir Susceptibilities of HIV-1 After 24 to 48 Weeks of Adefovir Dipivoxil Therapy: Genotypic and Phenotypic Analyses of Study GS-96-408
Author(s) -
Michael D. Miller,
Nicolas Margot,
Patrick D. Lamy,
M. Fuller,
Kristin E. Anton,
Andrew Mulato,
Julie M. Cherrington
Publication year - 2001
Publication title -
journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.162
H-Index - 157
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/00042560-200108150-00005
Subject(s) - adefovir , zidovudine , medicine , virology , placebo , lamivudine , genotype , didanosine , reverse transcriptase inhibitor , gastroenterology , stavudine , biology , sida , viral disease , human immunodeficiency virus (hiv) , hepatitis b virus , virus , genetics , pathology , alternative medicine , gene